CorVel Corp. 10-Q Summary: Quarter Ended September 30, 2002
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2002, and the six-month period ended on the same date. CorVel Corporation provides managed care services, primarily in the workers' compensation market, including provider bill review, independent medical examinations (IME), and diagnostic imaging services. The company operates a Preferred Provider Organization (PPO) known as CorCare.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2002 | Six Months Ended Sep 30, 2002 |
|---|---|---|
| Revenues | $69,353,000 | $135,654,000 |
| Gross Profit | $13,332,000 (19.2% margin) | $25,642,000 (18.9% margin) |
| Net Income | $4,091,000 | $8,120,000 |
| Earnings Per Share (Diluted) | $0.37 | $0.73 |
| Cash and Cash Equivalents | $5,548,000 (as of Sep 30, 2002) | N/A |
| Net Cash Provided by Operating Activities | N/A | $9,699,000 |
| Debt | $0 (No interest-bearing debt) | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 18.8% year-over-year for the quarter and 16.5% for the six-month period. This growth was driven by a 27% increase in provider program revenues (bill review, PPO, IME, and MRI services), largely due to the acquisition of AnciCare and increased volume in IME scheduling.
- Profitability: Net income rose 12.4% for the quarter and 12.3% for the six-month period compared to the prior year. Gross profit margins improved slightly (19.2% vs. 17.9% for the quarter) due to the higher mix of high-margin provider program services.
- Expenses: General and administrative (G&A) expenses increased as a percentage of revenue (9.7% vs. 7.9% for the quarter). Management attributed this primarily to the write-off of obsolete capitalized software.
- Liquidity: Cash and cash equivalents decreased from $12.6 million to $5.5 million over the six-month period. This decline was driven by investing activities, including the AnciCare acquisition and capital expenditures, as well as financing activities related to stock repurchases.
Guidance, Outlook, and Risks
Management Commentary: Management believes current cash balances and internally generated funds are sufficient to meet requirements for the next twelve months. The company continues to fund operations and capital expenditures primarily through cash flow from operations.
Strategic Actions:
- Acquisition: Completed the acquisition of AnciCare, PPO, Inc. in May 2002 to expand diagnostic imaging services. Contingent payments may be required if revenue targets are met.
- Stock Repurchase: Expanded the share repurchase plan by 1,000,000 shares in August 2002. The company has repurchased 5.0 million shares for $77 million since 1996.
Risks and Contingencies:
- Regulatory Environment: The company faces evolving state regulations regarding medical review services and workers' compensation, which could increase operational costs or limit service offerings.
- Competition: Increased competition from HMOs, PPOs, and insurers, particularly as legislation allows health plans to cover workers' compensation claims.
- Legal Liability: Potential exposure to litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
- Market Dynamics: Declines in workers' compensation claim volumes or costs in various states could adversely affect demand for services.
Investor Verification Checklist
- Verify the integration progress and revenue contribution of the AnciCare acquisition.
- Monitor the impact of the write-off of obsolete software on future G&A expense trends.
- Assess the sustainability of the 19% gross margin given the mix of provider program vs. patient management services.
- Review state-specific regulatory changes affecting medical review licensing and workers' compensation laws.
- Track the company's cash burn rate relative to its stock repurchase program and capital expenditure needs.